resorcinol has been researched along with Hyperplasia in 2 studies
resorcinol: RN given refers to parent cpd; structure in Merck Index, 9th ed, #7951
resorcinol : A benzenediol that is benzene dihydroxylated at positions 1 and 3.
Hyperplasia: An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nakamura, A | 1 |
Shirai, T | 1 |
Takahashi, S | 1 |
Ogawa, K | 1 |
Hirose, M | 2 |
Ito, N | 2 |
Yamaguchi, S | 1 |
Fukushima, S | 1 |
Hasegawa, R | 1 |
2 other studies available for resorcinol and Hyperplasia
Article | Year |
---|---|
Lack of modification by naturally occurring antioxidants of 3,2'-dimethyl-4-aminobiphenyl-initiated rat prostate carcinogenesis.
Topics: Aminobiphenyl Compounds; Animals; Antioxidants; Carcinogens; Catechols; Hydroquinones; Hyperplasia; | 1991 |
Modification by catechol and resorcinol of upper digestive tract carcinogenesis in rats treated with methyl-N-amylnitrosamine.
Topics: Animals; Carcinogens; Carcinoma; Catechols; Esophageal Neoplasms; Esophagus; Hyperplasia; Lung; Male | 1989 |